The CD38 influence on NADH metabolism and related tumor signaling [21] may explain such a role, and its anti-correlation with the expression of myosin 1C isoform A is consistent with this myosin’s proposed function [9,11] as a prostate cancer progression-associated molecule. This evidence concerns the gene CD38 and prostate cancer.